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Abstract 
Vibrio cholerae, the cause of seven noted pandemics, leads a dual lifecycle—one in the human host in its virulent 
form, and the other as a sessile, non-virulent bacterium in aquatic bodies in surface biofilms. Surface biofilms have 
been attributed to be associated with a ubiquitous protein domain present in all branches of bacteria, known as the 
GGD(/E)EF domain. While the diguanlyate cyclase activities of these proteins are universally established, the role of 
these proteins as diguanlyate-specific phosphodiesterases in conjunction with a EAL domain has also been reported. 
The VC0395_0300 protein from V. cholerae which shows biofilm forming abilities also acts as a phosphodiesterase. 
Interestingly, this GGD(/E)EF protein contains a EAL site in the reverse orientation. We attempted to mutate the GGEEF 
signature along the sequence by site-directed mutagenesis. The resultant mutants (Sebox5–7) did not show much 
difference in phosphodiesterase activity in comparison with the wild type protein (Sebox3), indicating the independ-
ence of the phosphodiesterase activity of the protein from the GGD(/E)EF domain. However, the ability of the mutants 
to form surface biofilm was significantly lesser in the case of mutations in the three central positions of the signature 
domain.
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Introduction
The Gram negative flagellate V. cholerae survives as a 
non-motile, non-virulent, biofilm in aquatic bodies in 
between cholera epidemics. Biofilms are resistant to 
external stress like antibiotics, chlorine, predators and 
other factors (Ryjenkov et al. 2005; Hammer and Bassler 
2009). Biofilm-forming bacteria have been shown to 
secrete an external exopolysaccharide matrix (Karatan 
and Watnick 2009). Proteins with a conserved GGD(/E)
EF domain have been implicated in the regulation of the 
polysaccharide production in Salmonella typhimurium, 
Pseudomonas aeruginosa and almost all eubacterial spe-
cies. A number of these GGD(/E)EF putative domains are 
also present in the V. cholerae genome as well, distributed 
across both chromosomes. GGD(/E)EF domain pro-
teins have mostly been shown to synthesize (as digua-
nylate synthases) the bacterial secondary messenger 
cyclic-di-GMP (c-di-GMP), whereas enzymes having an 
EAL or HD-GYP domain (phosphodiesterases) gener-
ally degrade the messenger (D’Argenio and Miller 2004; 
Tischler and Camilli 2004; Ryan et al. 2006; Yan and Chen 
2010; Hengge 2013). It has been accepted that an increase 
in the levels of c-di-GMP is usually associated with the 
formation of the exopolysaccharide matrix and the sur-
face biofilm in V. cholerae. On the other hand, a decrease 
in c-di-GMP concentrations due to phosphodiesterase 
(PDE) activity leads to the bacterium showing functional 
flagella and consequent loss of biofilm (Lim et  al. 2007; 
Waters et al. 2008).
Another common observation has been the coupling 
of these domains, viz., the GGD(/E)EF, HD-GYP and 
EAL domains with sensory domains like the PAS, GAF 
and DICT, suggesting a role for these proteins in sensing 
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environmental signals (D’Argenio and Miller 2004). How-
ever, the exact mechanisms of this synergy has not been 
deciphered yet as different ligands have been known to 
mediate the signaling process for different proteins. 
Additionally, it is an observed fact that a single bacte-
rium may possess multiple putative proteins which code 
for GGD(/E)EF or EAL or both. While Escherichia coli 
K12 codes for 12 proteins with GGD(/E)EF, 10 with EAL 
and 7 with both, P. aeruginosa encodes 17 GGD(/E)EF, 5 
EAL and 16 with both. Likewise, V. cholerae codes for 31 
GGD(/E)EF, 22 EAL and 10 with both (Lim et  al. 2007; 
Tamayo et  al. 2007; Waters et  al. 2008; Yan and Chen 
2010). However, mutation in a single protein can result 
in disruption of morphology for the bacterium. How or 
why this multiple coding system has been sustained and 
why morphological changes happen due to mutation in a 
single protein have also been subjects of intense debate.
Essentially, a diguanylate cyclase has been shown to 
have two active sites (Castiglione et  al. 2011). The cata-
lytically active A-site with a conserved GGD(/E)EF loop 
binds one monomer of GTP, which is the substrate. When 
two such substrate-loaded monomers come together in 
an antiparallel orientation, the synthesis of c-di-GMP 
takes place. The other site, the I-site, is known to bind 
the c-di-GMP and is often associated with the allosteric 
inhibition of diguanylate cyclase activity (Gao and Stock 
2009; Yang et al. 2011; Marmont et al. 2012). Therefore, 
a majority of the proteins with the GGD(/E)EF signature 
sequence have been found to possess diguanylate cyclase 
activity. On the other hand, there have been reports of 
proteins having unorthodox GGDEF signature sequences 
and therefore, lack of diguanylate cyclase activity. How-
ever, these proteins have still retained the ability to bind 
GTP at the active site (Christen et al. 2005).
The putative GGD(/E)EF protein VC0395_0300 from 
the chromosome I of V. cholerae classical strain O395 
shows the presence of a GGD(/E)EF domain, as well as 
a PAS domain signature, as determined from domain 
prediction software. This protein was overexpressed as a 
recombinant system in E. coli and purified. Subsequent 
determination of activity revealed the lack of digua-
nylate cyclase activity for the protein, but demonstrated 
the presence of phosphodiesterase activity. However, the 
VC0395_0300 protein was shown to have a distinct role 
in biofilm formation. Site-directed mutagenesis at the 
central GEE sites of VC0395_0300 generated mutants, 
all of which lacked biofilm forming ability. The phos-
phodiesterase activity was preserved in all the mutants; 
additionally, none of them showed any diguanylate 
cyclase activity. Interestingly, the VC0395_0300 protein 
does not possess an ‘EAL’ or ‘HD-GYP’ domain in its 
sequence, but an EAL signature in reverse (LAE), which 
is an aberration because all known phosphodiesterases 
reported till now have been shown to be associated with 
an ‘EAL’ or ‘HD-GYP’ signature.
Materials and methods
Bacterial strains and plasmids
Genomic DNA from V. cholerae classical strain O395 
was extracted and purified according to the method 
in (Bhuiyan et  al. 2012). E. coli BL21 (DE3) and DH5α 
were procured from Novagen. The gene encoding 
VC0395_0300 (putative GGDEF protein) from V. chol-
erae was PCR amplified with DreamTaq DNA polymer-
ase (Fermentas) and the following primers: Sebox 1A 
(BamHI, XhoI) 5′AATACTGGATCCATGAAAAATTG 
GCTGTG TCAGGCAGTG 3′ and 5′AATACT CTCG 
AGTTATTCTGTGGATTGGCGATAGATACA 3′. The 
restriction enzyme names are within parentheses, and 
their sequence in the primers indicated as underlined. 
For site-directed mutagenesis, the following primers 
were utilized: Sebox 5 (new_mutant at position 2 gener-
ating the second G): 5′ GATGATGAACTC TTCACgTC 
CCACACG 3′; Sebox 6 (new mutant at position 3 gen-
erating the first E): 5′ GATGATGAACTCTTtACCTCC 
CACACG 3′; Sebox 7 (new_mutant at position 4 gen-
erating the second E): 5′ GATGATGAACTtTTCAC 
CTCCCACACG 3′. The site of the mutation has been 
shown in italics in the above three primers. The amplified 
fragments were purified using QiAquick kit from Qiagen, 
and digested using restriction enzymes from Fermentas. 
This was cloned into the corresponding sites of the vector 
pGEX-6P-1 (GE Healthcare) in E. coli DH5α.
Protein expression and purification
VC0395_0300 was expressed as a recombinant GST-
fusion product in E. coli BL21 (DE3). A 2 litre bulk cul-
ture was induced by addition of 0.05  mM IPTG (final 
concentration) for 8  h at 16  °C and 180  rpm. The cells 
were then harvested by centrifugation and suspended in 
lysis buffer [50 mM Tris–HCl (pH 7.4) and 50 mM NaCl]. 
The suspension was lysed by sonication with low ampli-
tude pulses of 30 s duration each, followed by centrifuga-
tion to separate the insoluble fractions. The supernatant 
was loaded into glutathione agarose resin (GE Healthcare 
Life Sciences), which had been pre-equilibrated in a com-
patible buffer, for 1 h at 4 °C. The target protein fractions 
were eluted using an elution buffer containing 10  mM 
reduced glutathione and the purity of the protein was 
checked on a 10 % Tris–glycine SDS PAGE under dena-
turing conditions. The purified fractions were pooled and 
dialysed against a Tris buffer of pH 8.0. Protein concen-
tration was determined using Bradford reagent (Bradford 
1976) at each step.
Page 3 of 9Chouhan et al. AMB Expr  (2016) 6:2 
Cleavage of the GST tag
The GST tag being a 26 kDa fusion protein made it essen-
tial for the tag to be removed for further characterization 
of the GGEEF protein. Hence the tagged protein isolated 
previously was reloaded into the GST Sepharose column 
according to the conditions listed in the manufacturer’s 
protocol (Harper and Spiecher 2011). The resin-bound 
protein was treated with 10 units/mg of PreScission Pro-
tease (GE Healthcare Life Sciences) at 4  °C overnight. 
Subsequent washing and elution of the column resulted 
in purified VC0395_0300 bereft of GST tag. Similar 
method was employed for the extraction, purification 
and cleavage of the three mutants as well.
Biofilm formation and quantification assays
Biofilm formation assay was performed according to the 
method described previously (Boyd and O’Toole 2012). 
Briefly the method encompassed inoculation of fresh 
5 ml LB broth in glass tubes (18 × 150 mm) containing 
antibiotic with 1 % overnight bacterial cultures and incu-
bation at 37 °C with shaking at 120 rpm for 12 h. Thereaf-
ter, all the tubes were transfer to static culture conditions 
for incubation. The tubes were observed for the appear-
ance of thin slimy film or pellicles at the air–liquid inter-
face. Upon removal of all the liquid medium from the 
test tubes, the bacterial cells bound to the walls were 
stained with 0.2 % crystal violet for 5 min at room tem-
perature. Unbound excess crystal violet was removed by 
rinsing the tube with distilled water. Tubes were air dried 
at room temperature and photographed. This was repli-
cated for multiple sets for each day starting from 1  day 
to 7 days. For spectrophotometric quantification, the bio-
film was dissolved in 4  ml of 75  % ethanol and absorb-
ance noted using a spectrophotometer at 570 nm.
Motility assays
Motility test was performed utilizing the color conver-
sion of triphenyl tetrazolium chloride (TTC) as described 
in previous reports (Ball and Sellers 1966; An et al. 2010). 
In its oxidized form, TTC is a colorless compound that is 
absorbed into the bacterial cell which grows in its pres-
ence. Here, TTC is reduced to form  a red colored pig-
ment called formazan. To perform motility assay, single 
isolated colony was deep stabbed to a LB agar tube con-
taining TTC using a sterile inoculating needle and incu-
bated at 37 °C until growth was evident. Bacterial growth 
is indicated by the appearance of a red color formed due 
to the production of formazan.
In vitro phosphodiesterase activity assays
Purified wild type Sebox3 and the mutated strains 
(Sebox5, Sebox6 and Sebox7) were assayed for in  vitro 
phosphodiesterase activity. The protein concentration 
was kept uniform after performing Bradford assay. PDE 
activity was performed using chemically synthesized 
substrate bis(p-nitrophenyl) phosphate (obtained from 
Sigma Aldrich) using standard protocol (Liu et al. 2010) 
with some minor changes. 50 μl of reaction mixture was 
prepared consisting of 50 mM Tris–HCl (pH 7.4), 10 mM 
MnCl2, 5 mM bis-pNPP to which was added 50 μl of the 
protein sample. The reaction mixture was mixed well 
and incubated for 8 h at 37  °C. The amount of released 
p-nitrophenol was detected and quantified by a Shi-
madzu UV–Vis spectrophotometer at an OD of 410 nm. 
Controls were set up without the addition of the protein 
and enzyme activity was compared in triplicate individ-
ual assays to ascertain the reproducibility of the reaction. 
Benziman had reported that Ca2+ strongly inhibited the 
phosphodiesterase activity in Gluconacetobacter xyli-
nus (Ross et al. 1986, 1990). Therefore, we added 10 mM 
CaCl2 to the reaction mixture to check for Ca2+ induced 
inhibition in the wild type as well as mutant samples.
Fluorescence spectroscopy
To estimate the position of the tryptophans (two in 
number) present in the wild type and mutants, fluores-
cence studies were carried out in a JASCO FP8200 spec-
trofluorimeter. Both the excitation and emission band 
passes were kept at 5 nm. For the denaturation study, a 
series of fresh solutions of guanidinium hydrochloride 
(GdnHCl) having concentrations in the range of 0.5–5 M 
in 50  mm Tris HCl buffer (pH 8.0) were prepared and 
the proteins were added to a final concentration of 7 μM. 
Proteins were incubated separately in GdnHCl contain-
ing buffer overnight at 25  °C. Equal volumes of buffer 
were added to the same volume of GdnHCl solutions 
and these mixtures were used as blank. The excitation 
wavelength was kept at 295 nm and the emission spectra 
were noted.
Comparison of homology models
A BLAST query was performed with the sequence of 
VC0395_0300 against all PDB structures to find homo-
logues. The protein from Marinobacter aquaeolei digua-
nylate cyclase complexed with c-di-GMP (pdb id. 3ign) 
was the best match in terms of query coverage and 
E-value. There was approximately 40  % sequence simi-
larity between the sequences of VC0395_0300 and 3ign. 
A homology model of VC0395_0300 was constructed 
using the Modeller Suite (Version 9.1). The initial model 
was further improved by energy minimization using 
GROMACS 4.5 (Berendsen et  al. 1995; Abraham and 
Gready 2011) software package. After the optimization 
procedure, minimized model was validated using PDB-
sum where the evaluation was based on standard bond 
length, bond angle, Ramachandran plot, etc. (Laskowski 
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2001). A similar method was adopted for all the three 
mutants and the modeled structures of Sebox 3, 5, 6 
and 7 were compared for the surface architecture of the 
GGEEF region.
Results
Low cell viability has been reported for GGD(/E)EF pro-
teins previously expressed from various sources (Ryjen-
kov et al. 2005). The same was evident for our clones as 
well, and transformation efficiency was abysmally low. 
During expression and extraction, care had to be taken 
for obtaining active protein in the soluble fractions. Ini-
tially, recombinant wild type Sebox3 was obtained in 
small quantity in the supernatant fractions and had to be 
standardized against buffer conditions to improve purity. 
The need for larger culture volumes was necessitated by 
the low yield of the protein after cleavage of tag. Simi-
larly, for the mutants as well, yield needed to be stand-
ardized to achieve workable quantities (Fig. 1). Again, the 
tagless proteins were found to be unstable in solution.
Mutation in the ‘GEE’ positions affects biofilm formation 
in V. cholerae
Site directed mutagenesis at the positions G, E and E of 
the GGEEF sequence in VC0395_0300 resulted in the 
generation of mutants with altered amino acids. While 
Sebox5 mutants had an arginine in place of the glycine, 
Sebox6 had the glutamate replaced by lysine, and Sebox7 
also had a lysine in place of the glutamate. The generated 
mutants were checked by sequencing and also by blot-
ting against anti-GST antibodies (GE Healthcare Life 
Sciences).
Growth of the mutants in LB medium and transfer to 
static conditions for observation of biofilm formation was 
undertaken for separate sets at 2, 4 and 7 days intervals. 
After both 4 and 7 days, it was observed that the biofilm 
formation was significantly lower for the mutant Sebox5, 
6 and 7 cultures when compared to the Sebox3 wild type. 
While the formation of biofilms decreased almost by 
threefolds in Sebox5 and 7, a twofold decrease was evi-
dent in Sebox6 (Fig. 2a, b).
Fig. 1 Purification profile of tagged Sebox5 (left) and tagless Sebox5 
(right) against pre-stained molecular weight ladder
Fig. 2 Biofilm formation in wild type Sebox3 and mutants Sebox5, 6 
and 7. a Crystal violet stained biofilm in Sebox3 strains, lack of biofilm 
formation in Sebox5, 6 and 7. b Spectrophotometric estimation of 
biofilm formation by dissolving the biofilm formed in a and measure-
ment of absorbance at a wavelength of 570 nm
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The complementary motility assay was also performed 
to visualize the loss of biofilm formation abilities in the 
mutants. The TTC assay essentially marks out the migra-
tion of the bacterium from the zone of inoculation by 
the needle. After inoculation in the stab culture, the test 
tubes were allowed to incubate at 37 °C for 2 days with-
out shaking. For the wild type strain Sebox3, there was 
no migration from the initial stab line, and no regions of 
color were visible. However, for the mutant strains, there 
was visible spread of the red formazan zone away from 
the site of inoculation of the initial stab (Fig. 3). All the 
three strains showed more-or-less comparable zone of 
motility, confirming our initial observations about loss of 
biofilm formation ability in the three mutants.
The VC0395_0300 protein and the mutants do not 
have diguanylate cyclase activity but display in vitro 
phosphodiesterase activity
Since almost all GGD(/E)EF proteins display cyclic 
diguanylate activity, the proteins were initially assayed for 
the production of c-di-GMP, using the method employed 
previously (Ryjenkov et al. 2005). Briefly, a reaction mix-
ture containing 5 μM protein, 10 mM MgCl2, and 50 mM 
NaCl was treated with 5 μM of GTP (Sigma Aldrich). The 
reaction mixture was prewarmed and the reaction was 
carried out for 0, 5, 15, 30, and 60  min. Aliquots were 
withdrawn at the given time intervals, heated in a boiling 
water bath for 3 min, 0.5 mM EDTA was added and cen-
trifuged at 10,000g for 10 min.
The samples were injected into a X Terra RP18 column 
(250 mm × 4.6) from Waters and separated in an Agilent 
1220 Infinity LC system for a total run time of 30 min at 
a flow rate of 0.6 ml/min. 20 mM triethyl amine in 9 % 
methanol and water was used as the solvent system for 
the process. NADP was added to the sample prior to 
injection as a standard. However, even after repeated 
runs with wild type and mutant proteins (at least four 
times for each), no peak corresponding to c-di-GMP was 
observed, indicating the absence of diguanylate cyclase 
activity in VC0395_0300 as well as its mutants.
The wild type and the mutants were both assayed for 
in  vitro phosphodiesterase activity with bis(p-nitrophe-
nyl) phosphate as the substrate. To our surprise, all the 
three mutants as well as the wild type demonstrated 
considerable activity with OD410 values ranging from an 
average of 0.41 (Sebox3) to 0.54 (Sebox7) (Fig.  4). Trip-
licate reactions confirmed the same for all four sets. 
Again, inhibition with CaCl2 reduced the OD410 value 
almost fourfolds indicating the inhibition of PDE activ-
ity by Ca2+, as had been the hallmark of other proteins 
having PDE activity. However, it is indeed notable that 
the VC0395_0300 protein does not have any EAL or HD-
GYP domain  in the correct orientation, ones that are 
usually associated with PDE activity. Since the mutants 
do not show any significant change in the PDE activity, it 
can also be safely concluded that the PDE activity is not 
associated with the GGEEF signature sequence.
Estimation of changes in structure of mutants 
through fluorescence
Intrinsic tryptophan fluorescence (λex at 295  nm) was 
observed to infer any changes in the proteins’ architec-
ture due to the effect of the mutations. The fluorescence 
spectra after denaturation with guanidinium hydrochlo-
ride showed a shift in the emission maxima (λmax) for 
both the wild type and mutant proteins (Fig.  5). While 
this shift was more pronounced in the case of the wild 
type protein, it was considerably less for the mutants. 
One of the tryptophans is within the first four amino 
acids from the N-terminal, and possibly would not be 
folded into the interior. The other tryptophan is near 
about the middle of the sequence and contributes to the 
Fig. 3 Assay for motility. Triphenyl tetrazolium chloride (TTC) forms 
a red colored compound, formazan, when absorbed into a bacterial 
cell. While Sebox3 shows almost no motility, Sebox5, 6 and 7 show 
migration from the initial stab line
Fig. 4 In vitro phosphodiesterase activity. Release of p-nitrophenol 
was measured at a wavelength of 410 nm after action of the enzyme 
on the substrate, bis(p-nitrophenyl) phosphate
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red shift. A bigger shift in λmax for an unfolded protein 
indicates a complete exposure on unfolding for a buried 
tryptophan. On the other side, a smaller shift signifies 
the tryptophan to be partially accessible for fluorescence 
in the folded state, which seems to be the case for the 
mutants. This was indicative of some structural rear-
rangement resulting in partial exposition of the interior 
tryptophan in the mutants vis-à-vis the wild type Sebox3.
Structural changes in the interface from homology models
The modeled structure was aligned against other crys-
tallized GGDEF proteins structures (4h54, 3tvk, 3qyy, 
3ign) using PyMOL (The PyMOL Molecular Graph-
ics System 2002). All these proteins aligned almost per-
fectly at their GGD(/E)EF regions. The GGD(/E)EF 
domain in VC0395_0300 is made up of a five-stranded 
beta sheet surrounded by multiple alpha helices and the 
GGEEF sequence occurs in the turn between the first two 
antiparallel strands of the sheet. This is in agreement with 
the three other structures which have been cited before 
(Lim et al. 2007; Tamayo et al. 2007; Gao and Stock 2009).
Similarly, models were constructed for the mutant 
proteins Sebox5–7, and the model with the least free 
energy was chosen. All the generated models had more 
than 97 % of the residues in the favourable regions of the 
Ramachandran plot and the rest in the allowed regions. 
The mutant structures also show more or less similar 
architecture with regard to the domain, but, there is sig-
nificant difference in the GGEEF turn between β1 and β2. 
This has been highlighted in Fig. 6.
While the structure of the PleD from P. aeruginosa and 
the XCC4471GGDEF protein from Xanthomonas campes-
tris showed the presence of compact interaction between 
the two consecutive, highly conserved glycines in the first 
two sites, generation of a G to R mutation in Sebox5 has 
disrupted the compactness which is essential for inter-
action with the c-di-GMP. Comparison of the surface 
morphology of the wild type and mutant proteins reveal 
significant differences in the surface of the wild type and 
the mutant Sebox5. The introduction of the lysine in 
place of the first glutamate in Sebox6 also changes the 
surface of the turn. It is to be noted that both Sebox5 
Fig. 5 Shift in λmax in the wild type and mutant proteins before a and after b complete unfolding with guanidinium hydrochloride
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and Sebox6 show a significant loss of biofilm formation 
abilities compared to the wild type. However, the lack of 
diguanylate cyclase activity in any of the proteins does 
not allow us a clear hypothesis.
Discussions
V. cholerae possesses multiple sequences in the genome 
encoding GGD(/E)EF domain proteins, EAL proteins 
or both. One of them with a putative GGEEF domain, 
VC0395_0300 was chosen for characterization. To 
understand the effects of mutation at the GGEEF signa-
ture sequence, site-directed mutagenesis using the mega 
primer method was utilized to generate three mutants 
Sebox5, Sebox6 and Sebox7 representing mutations at the 
second G, first E and the second E, respectively. Both the 
wild type (Sebox3) and mutants showed considerable loss 
of cell viability, a trait often associated with recombinant 
GGD(/E)EF proteins. Functional characterization of the 
wild type protein showed significant biofilm formation, 
while the mutants had a remarkable loss of biofilm-form-
ing ability, the most pronounced being Sebox6. Enzy-
matic assays to determine diguanylate cyclase activity did 
not reveal any evidence for the formation of c-di-GMP 
when the wild type and mutant proteins were allowed 
to react with the substrate GTP. Interestingly though, 
in  vitro phosphodiesterase activity was demonstrated 
by Sebox3, 5, 6 and 7 despite the lack of an EAL or HD-
GYP domain in the sequence. However, this confirmed 
Fig. 6 Differences in surface morphology in the GGEEF region of wild type (a), when the second G is mutated to R (Sebox5) (b), first E mutated to 
K (Sebox6) (c), second E mutated to K (Sebox7) (d). The first G is depicted in red, second G in blue, first E in green, second E in orange, and the F in 
magenta. The first and the second antiparallel strands of the beta sheet have been demarcated in a
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the fact that the phosphodiesterase activity does not have 
any correlation with the GGEEF domain, as mutagen-
esis did not affect the phosphodiesterase activity. This 
is in line with newer findings of the activities and roles 
of GGD(/E)EF proteins from some unorthodox systems. 
Recent inputs by authors (Petrova et  al. 2015) reiterate 
the diversity and complexity of diguanylate cyclases bear-
ing GGD(/E)EF signatures in the regulation of biofilm 
formation apart from the conventional role of conversion 
of GTP to c-di-GMP.
Looking for an explanation to the loss of biofilm form-
ing ability in the mutants as compared to the wild type, 
unfolding studies with guanidinium hydrochloride  were 
undertaken and subsequent fluorescence were observed. 
The results point to some rearrangement in the archi-
tecture of the mutant proteins compared to the wild 
type as revealed by the shift in the emission maxima of 
tryptophan fluorescence. The homology derived model 
of the wild type protein showed structural familiarity 
with GGD(/E)EF domains from other structures. How-
ever, surface architecture of the mutants Sebox5 and 
Sebox6 show marked departure from the surface of the 
wild type GGEEF turn. From the observed properties, 
VC0395_0300 seems to be unique in its function, as it 
displays a GGEEF domain without a diguanylate cyclase 
activity, but shows a phosphodiesterase activity inspite 
of the absence of the EAL domain in the correct orienta-
tion. While we need to ascertain whether there is a GTP 
binding site in the protein or whether c-di-GMP binds to 
it at all, it is certainly a novel report of a GGEEF protein 
with phosphodiesterase activity. The shift in structure 
maybe postulated as a cause for the differences in biofilm 
forming abilities of the wild type versus the mutants, but 
other biophysical characterization would be necessary to 
fully understand the basis.
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